Colony Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$3.07M Buy
80,387
+5
+0% +$205 0.05% 281
2023
Q2
$2.9M Sell
80,382
-104
-0.1% -$3.55K 0.04% 288
2023
Q1
$3.07M Sell
80,486
-1,092
-1% -$51.2K 0.05% 285
2022
Q4
$4.64M Buy
81,578
+1,555
+2% +$79.6K 0.07% 242
2022
Q3
$3.16M Sell
80,023
-1,292
-2% -$57.1K 0.06% 267
2022
Q2
$3.58M Buy
81,315
+511
+0.6% +$22.1K 0.06% 247
2022
Q1
$3.22M Buy
80,804
+859
+1% +$30.6K 0.05% 295
2021
Q4
$3.21M Buy
79,945
+5,787
+8% +$216K 0.06% 272
2021
Q3
$3.02M Buy
74,158
+713
+1% +$29.8K 0.06% 258
2021
Q2
$3.33M Sell
73,445
-103
-0.1% -$4.56K 0.07% 227
2021
Q1
$3.07M Sell
73,548
-6,549
-8% -$299K 0.06% 249
2020
Q4
$3.42M Sell
80,097
-1,064
-1% -$38.2K 0.08% 209
2020
Q3
$2.13M Sell
81,161
-40,334
-33% -$1.12M 0.06% 257
2020
Q2
$3.26M Buy
121,495
+107
+0.1% +$2.41K 0.09% 190
2020
Q1
$2.18M Buy
121,388
+50,468
+71% +$958K 0.07% 228
2019
Q4
$1.26M Buy
70,920
+660
+0.9% +$11.4K 0.03% 364
2019
Q3
$1.09M Sell
70,260
-230
-0.3% -$3.79K 0.03% 359
2019
Q2
$1.21M Buy
70,490
+1,095
+2% +$17.7K 0.04% 348
2019
Q1
$1.12M Buy
69,395
+28,330
+69% +$459K 0.05% 277
2018
Q4
$601K Sell
41,065
-31,355
-43% -$500K 0.03% 318
2018
Q3
$1.32M Sell
72,420
-220
-0.3% -$3.85K 0.07% 245
2018
Q2
$1.23M Buy
+72,640
New +$1.37M 0.06% 250

Other funds holding HALO

Colony Group's HALO Position: Q3 2023 in Review

Colony Group increased its Halozyme (HALO) stake by 0.01% in Q3 2023, buying an estimated $205 and bringing the position to 80,387 shares worth $3.07M. The position accounts for 0.05% of the portfolio, ranked #281.

Colony Group first reported a position in HALO in Q2 2018 and has held it in 22 quarters since. The position peaked at $4.64M in Q4 2022. 389 funds tracked by Wall St. Rank hold HALO as of Q3 2023.

  • Colony Group held 80,387 shares of Halozyme worth $3.07M as of Q3 2023.
  • Colony Group bought 5 Halozyme shares in Q3 2023, an estimated $205.
  • Halozyme made up 0.05% of Colony Group's portfolio in Q3 2023, its #281 holding.
  • Colony Group first reported a position in Halozyme in Q2 2018 and has held it in 22 quarters since.
  • Colony Group's Halozyme position peaked at $4.64M in Q4 2022.
  • 389 funds tracked by Wall St. Rank held Halozyme as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.